Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Acute Relapsing Multiple Sclerosis

glucose, (beta-d)-isomer has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basdeo, SA; Costelloe, L; Dungan, LS; Fletcher, JM; Higgins, SC; Kelly, PJ; Kinsella, K; Lonergan, R; Mills, KH; Sweeney, CM; Tubridy, N1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Acute Relapsing Multiple Sclerosis

ArticleYear
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.
    Brain, behavior, and immunity, 2011, Volume: 25, Issue:6

    Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-alpha; Interferon-beta; Interleukins; Male; Mice; Mice, Inbred Strains; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Th17 Cells; Toll-Like Receptors; Young Adult; Zymosan

2011